Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis
Status:
Completed
Trial end date:
2016-04-05
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the efficacy of a rituximab regimen based on rate of ANCA
and CD19 lymphocytes for maintenance treatment in systemic ANCA-associated vasculitis:
prospective, multicenter, controlled, randomized comparative study of two rituximab regimens:
one based on ANCA and CD19 lymphocytes versus systematic infusions.